Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior?
نویسندگان
چکیده
Recent case reports in medical literatures suggest that more and more second-generation atypical antipsychotics (AAs) have been prescribed for off-label use; quetiapine (Brand name: Seroquel®) showed increase in its trend for off-label use. Little is known about the reasons behind this trend, although historical sedative and hypnotic prescription patterns suggest that despite relatively superior safety profiles of quetiapine (especially for movement disorders), it may be used for treating substance abuse disorder. In addition, recent studies have shown a strong potential for misuse and abuse (MUA) of quetiapine beyond Food and Drug Administration-approved indications. This includes drug-seeking behaviors, such as feigning symptoms, motivated by quetiapine and use of quetiapine in conjunction with alcohol. Quetiapine appears to be the most documented AA with street values bartered illicitly on the street. A recent report from the Drug Abuse Warning Network has shown a high prevalence of quetiapine-related emergency department visits involving MUA. Several other case studies have found that quetiapine causes seeking behaviors observed in substance use disorder. In fact, the majority of quetiapine MUA involved patients diagnosed with substance use disorder. In the absence of a definitive mechanism of action of quetiapine's reinforcing properties, it is imperative to gather robust evidence to support or refute increasing off-label use of AAs.
منابع مشابه
[Misuse and abuse of quetiapine].
Quetiapine is an atypical antipsychotic agent, frequently used in psychiatry, often for symptomatic treatment against a number of mental disorders differing from the registration indications. One of the use is to soothe the clinical conditions caused by the use of various psychoactive substances. The paper presents and discusses the reports of quetiapine misuse, abuse, and even mental addiction...
متن کاملDependence Potential of Quetiapine: Behavioral Pharmacology in Rodents
Quetiapine is an atypical or second-generation antipsychotic agent and has been a subject of a series of case report and suggested to have the potential for misuse or abuse. However, it is not a controlled substance and is not generally considered addictive. In this study, we examined quetiapine's dependence potential and abuse liability through animal behavioral tests using rodents to study th...
متن کاملEmergency Department Visits Involving Misuse and Abuse of the Antipsychotic Quetiapine: Results from the Drug Abuse Warning Network (DAWN)
Case reports in medical literature suggest that the atypical antipsychotic quetiapine, a medication not previously considered to have abuse potential, is now being subject to misuse and abuse (MUA; ie, taken when not prescribed for them or used in a way other than instructed by their health professional). Here we present systematic, nationally representative data from the 2005 to 2011 Drug Abus...
متن کاملCross-country Comparison of Treatment Policies Facing the Drug Abuse in Five Selected Countries
Background: Drug abuse is one of the main problems of human's life; thus communities have been thinkingabout the solution of this problem. The present study aimed to compare the general features of drug abusetreatment policies, war on drugs (WOD), and harm reduction (HR), in the selected countries.Methods: T...
متن کاملAtypical Antipsychotic Drug - Quetiapine Fumerate and its Analytical Techniques: A Review
Psychosis is a mental illness of severe type in which the patient loses touch with reality. A person with this problem change in his way of thinking, believing or perceiving and behaving. Since nowadays youngsters are greatly affected by this disease, many Antipsychotic drugs are introduced and used for the treatment. The present review describes information regarding a atypical antipsychotic d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 6 شماره
صفحات -
تاریخ انتشار 2017